Quality of life is impaired in myelin oligodendrocyte glycoprotein antibody associated disease.
Yana SaidDimitrios Christos LadakisJulia M LefelarJenny M KhazenJennifer GouldKathryn C FitzgeraldElias S SotirchosPublished in: Multiple sclerosis journal - experimental, translational and clinical (2024)
People with MOGAD may exhibit impairment in multiple domains of QoL. Practicing clinicians should be aware of this burden in MOGAD. Further research is needed to better understand factors associated with QoL impairment in MOGAD.